{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:38:18Z","timestamp":1794865098731,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Functional somatic symptoms and disorders are common and complex phenomena involving both bodily and brain processes. They pose major challenges across medical specialties. These disorders are common and have significant impacts on patients\u2019 quality of life and healthcare costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>We outline five problems pointing to the need for a new classification: (1) developments in understanding aetiological mechanisms; (2) the current division of disorders according to the treating specialist; (3) failure of current classifications to cover the variety of disorders and their severity (for example, patients with symptoms from multiple organs systems); (4) the need to find acceptable categories and labels for patients that promote therapeutic partnership; and (5) the need to develop clinical services and research for people with severe disorders.<\/jats:p>\n                    <jats:p>We propose \u2018functional somatic disorders\u2019 (FSD) as an umbrella term for various conditions characterised by persistent and troublesome physical symptoms. FSDs are diagnosed clinically, on the basis of characteristic symptom patterns. As with all diagnoses, a diagnosis of FSD should be made after considering other possible somatic and mental differential diagnoses. We propose that FSD should occupy a neutral space within disease classifications, favouring neither somatic disease aetiology, nor mental disorder. FSD should be subclassified as (a) multisystem, (b) single system, or (c) single symptom. While additional specifiers may be added to take account of psychological features or co-occurring diseases, neither of these is sufficient or necessary to make the diagnosis. We recommend that FSD criteria are written so as to harmonise with existing syndrome diagnoses. Where currently defined syndromes fall within the FSD spectrum \u2013 and also within organ system-specific chapters of a classification \u2013 they should be afforded dual parentage (for example, irritable bowel syndrome can belong to both gastrointestinal disorders and FSD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We propose a new classification, \u2018functional somatic disorder\u2019, which is neither purely somatic nor purely mental, but occupies a neutral space between these two historical poles. This classification reflects both emerging aetiological evidence of the complex interactions between brain and body and the need to resolve the historical split between somatic and mental disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-1505-4","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:10:27Z","timestamp":1583176227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":264,"title":["Functional somatic disorders: discussion paper for a new common classification for research and clinical use"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of the EURONET-SOMA Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0233-2431","authenticated-orcid":false,"given":"Christopher","family":"Burton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Henningsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"L\u00f6we","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Rief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"1505_CR1","first-page":"279","volume":"112","author":"H Haller","year":"2015","unstructured":"Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Dtsch Arztebl Int. 2015;112:279\u201387.","journal-title":"Dtsch Arztebl Int"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0022-3999(01)00223-9","volume":"51","author":"C Nimnuan","year":"2001","unstructured":"Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res. 2001;51:361\u20137.","journal-title":"J Psychosom Res"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpsychores.2017.04.003","volume":"97","author":"A Weigel","year":"2017","unstructured":"Weigel A, Husing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, et al. A European research network to improve diagnosis, treatment and care for patients with persistent somatic symptoms: work report of the EURONET-SOMA conference series. J Psychosom Res. 2017;97:136\u20138.","journal-title":"J Psychosom Res"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fpsyt.2018.00151","volume":"9","author":"CM van der Feltz-Cornelis","year":"2018","unstructured":"van der Feltz-Cornelis CM, Elfeddali I, Werneke U, Malt UF, Van den Bergh O, Schaefert R, et al. A European research agenda for somatic symptom disorders, bodily distress disorders, and functional disorders: results of an estimate-talk-estimate Delphi expert study. Front Psychiatr. 2018;9:151.","journal-title":"Front Psychiatr"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/PSY.0000000000000502","volume":"79","author":"W Rief","year":"2017","unstructured":"Rief W, Burton C, Frostholm L, Henningsen P, Kleinstauber M, Kop WJ, et al. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: European network on somatic symptom disorders recommendations. Psychosom Med. 2017;79:1008\u201315.","journal-title":"Psychosom Med"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/PSY.0000000000000588","volume":"80","author":"P Henningsen","year":"2018","unstructured":"Henningsen P, Gundel H, Kop WJ, Lowe B, Martin A, Rief W, et al. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom Med. 2018;80:422\u201331.","journal-title":"Psychosom Med"},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fpsyt.2018.00646","volume":"9","author":"S Kohlmann","year":"2018","unstructured":"Kohlmann S, Lowe B, Shedden-Mora MC. Health care for persistent somatic symptoms across Europe: a qualitative evaluation of the EURONET-SOMA expert discussion. Front Psychiatry. 2018;9:646.","journal-title":"Front Psychiatry"},{"key":"1505_CR8","unstructured":"EURONET-SOMA. https:\/\/www.euronet-soma.eu. Accessed 20 Jan 2020."},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/YCO.0000000000000089","volume":"27","author":"W Rief","year":"2014","unstructured":"Rief W, Isaac M. The future of somatoform disorders: somatic symptom disorder, bodily distress disorder or functional syndromes? Curr Opin Psychiatr. 2014;27:315\u20139.","journal-title":"Curr Opin Psychiatr"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jpsychores.2009.09.004","volume":"68","author":"F Creed","year":"2010","unstructured":"Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than \u2018medically unexplained symptoms\u2019? J Psychosom Res. 2010;68:5\u20138.","journal-title":"J Psychosom Res"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(98)08320-2","volume":"354","author":"S Wessely","year":"1999","unstructured":"Wessely S, Nimnuan M, Sharpe M. Functional somatic syndromes: one or many. Lancet. 1999;354:936\u20139.","journal-title":"Lancet."},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1176\/appi.psy.48.4.277","volume":"48","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Sharpe M, Sykes R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics. 2007;48:277\u201385.","journal-title":"Psychosomatics."},{"key":"1505_CR13","volume-title":"International statistical classification of diseases and related health problems (11th revision)","author":"World Health Organization (WHO)","year":"2018","unstructured":"World Health Organization (WHO). International statistical classification of diseases and related health problems (11th revision). Geneva: WHO; 2018."},{"key":"1505_CR14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5)","author":"American Psychiatric Association (APA)","year":"2013","unstructured":"American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-5). Washington, DC: APA; 2013."},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jpsychores.2010.02.004","volume":"68","author":"P Fink","year":"2010","unstructured":"Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68:415\u201326.","journal-title":"J Psychosom Res"},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpsychores.2016.10.002","volume":"91","author":"DP Goldberg","year":"2016","unstructured":"Goldberg DP, Reed GM, Robles R, Bobes J, Iglesias C, Fortes S, et al. Multiple somatic symptoms in primary care: a field study for ICD-11 PHC, WHO\u2019s revised classification of mental disorders in primary care settings. J Psychosom Res. 2016;91:48\u201354.","journal-title":"J Psychosom Res"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/wps.20353","volume":"15","author":"O Gureje","year":"2016","unstructured":"Gureje O, Reed GM. Bodily distress disorder in ICD-11: problems and prospects. World Psychiatry. 2016;15:291\u20132.","journal-title":"World Psychiatry"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PSY.0b013e31802e46eb","volume":"69","author":"P Fink","year":"2007","unstructured":"Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med. 2007;69:30\u20139.","journal-title":"Psychosom Med"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/fampra\/cms037","volume":"30","author":"TP Lam","year":"2013","unstructured":"Lam TP, Goldberg DP, Dowell AC, Fortes S, Mbatia JK, Minhas FA, et al. Proposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group study. Fam Pract. 2013;30:76\u201387.","journal-title":"Fam Pract"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV \u2013 functional GI disorders: disorders of gut\u2013brain interaction. Gastroenterology. 2016;150:1257\u201361.","journal-title":"Gastroenterology."},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, H\u00e4user W, Katz RL, et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319\u201329.","journal-title":"Semin Arthritis Rheum"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.psyneuen.2018.11.032","volume":"100","author":"A Russell","year":"2019","unstructured":"Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, et al. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. 2019;100:276\u201385.","journal-title":"Psychoneuroendocrinology."},{"issue":"Suppl 105","key":"1505_CR23","first-page":"74","volume":"35","author":"M Rizzi","year":"2017","unstructured":"Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, et al. Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clin Exp Rheumatol. 2017;35(Suppl 105):74\u201380.","journal-title":"Clin Exp Rheumatol"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2362.2011.02575.x","volume":"42","author":"J Nijs","year":"2012","unstructured":"Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Investig. 2012;42:203\u201312.","journal-title":"Eur J Clin Investig"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/BST20170503","volume":"46","author":"C Tomas","year":"2018","unstructured":"Tomas C, Newton J. Metabolic abnormalities in chronic fatigue syndrome\/myalgic encephalomyelitis: a mini-review. Biochem Soc Trans. 2018;46:547\u201353.","journal-title":"Biochem Soc Trans"},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpsychores.2015.01.003","volume":"78","author":"JH Bourke","year":"2015","unstructured":"Bourke JH, Langford RM, White PD. The common link between functional somatic syndromes may be central sensitisation. J Psychosom Res. 2015;78:228\u201336.","journal-title":"J Psychosom Res"},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/17437199.2018.1521730","volume":"13","author":"LM McAndrew","year":"2018","unstructured":"McAndrew LM, Crede M, Maestro K, Slotkin S, Kimber J, Phillips LA. Using the common-sense model to understand health outcomes for medically unexplained symptoms: a meta-analysis. Health Psychol Rev. 2018;13:427\u201346.","journal-title":"Health Psychol Rev"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0022-3999(01)00224-0","volume":"51","author":"C Nimnuan","year":"2001","unstructured":"Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res. 2001;51:549\u201357.","journal-title":"J Psychosom Res"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpsychores.2018.05.015","volume":"111","author":"LM McAndrew","year":"2018","unstructured":"McAndrew LM, Friedlander ML, Alison Phillips L, L Santos S, Helmer DA. Concordance of illness perceptions: The key to improving care of medically unexplained symptoms. J Psychosom Res. 2018;111:140\u20132.","journal-title":"J Psychosom Res"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/0141076814559082","volume":"108","author":"C Burton","year":"2015","unstructured":"Burton C, Lucassen P, Aamland A, TO H. Explaining symptoms after negative tests: towards a rational explanation. J R Soc Med. 2015;108:84\u20138.","journal-title":"J R Soc Med"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jpsychores.2015.02.013","volume":"78","author":"F Picariello","year":"2015","unstructured":"Picariello F, Ali S, Moss-Morris R, Chalder T. The most popular terms for medically unexplained symptoms: the views of CFS patients. J Psychosom Res. 2015;78:420\u20136.","journal-title":"J Psychosom Res"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2049463714535372","volume":"9","author":"EM Marks","year":"2015","unstructured":"Marks EM, Hunter MS. Medically unexplained symptoms: an acceptable term? Br J Pain. 2015;9:109\u201314.","journal-title":"Br J Pain"},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1136\/bmj.325.7378.1449","volume":"325","author":"J Stone","year":"2002","unstructured":"Stone J, Wojcik W, Durrance D, Carson A, Lewis S, MacKenzie L, et al. What should we say to patients with symptoms unexplained by disease? The \u2018number needed to offend\u2019. BMJ. 2002;325:1449\u201350.","journal-title":"BMJ."},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12875-017-0592-6","volume":"18","author":"M Rosendal","year":"2017","unstructured":"Rosendal M, Olde Hartman TC, Aamland A, van der Horst H, Lucassen P, Budtz-Lilly A, et al. \u2018Medically unexplained\u2019 symptoms and symptom disorders in primary care: prognosis-based recognition and classification. BMC Fam Pract. 2017;18:18.","journal-title":"BMC Fam Pract"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.pec.2016.11.015","volume":"100","author":"M-L Johansen","year":"2017","unstructured":"Johansen M-L, Risor MB. What is the problem with medically unexplained symptoms for GPs? A meta-synthesis of qualitative studies. Patient Educ Couns. 2017;100:647\u201354.","journal-title":"Patient Educ Couns"},{"key":"1505_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.pec.2012.12.015","volume":"91","author":"L Shattock","year":"2013","unstructured":"Shattock L, Williamson H, Caldwell K, Anderson K, Peters S. \u2018They\u2019ve just got symptoms without science\u2019: medical trainees\u2019 acquisition of negative attitudes towards patients with medically unexplained symptoms. Patient Educ Counsel. 2013;91:249\u201354.","journal-title":"Patient Educ Counsel"},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","volume":"160","author":"RD Treede","year":"2019","unstructured":"Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic Ppain for the international classification of diseases (ICD-11). Pain. 2019;160:19\u201327.","journal-title":"Pain."},{"key":"1505_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","volume":"160","author":"M Nicholas","year":"2019","unstructured":"Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160:28\u201337.","journal-title":"Pain."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-1505-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T19:07:21Z","timestamp":1614712041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-1505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-1505-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}